Global and national laboratory networks support high quality surveillance for measles and rubella
- PMID: 28582561
- DOI: 10.1093/inthealth/ihx017
Global and national laboratory networks support high quality surveillance for measles and rubella
Abstract
Laboratory networks are an essential component of disease surveillance systems because they provide accurate and timely confirmation of infection. WHO coordinates global laboratory surveillance of vaccine preventable diseases, including measles and rubella. The more than 700 laboratories within the WHO Global Measles and Rubella Laboratory Network (GMRLN) supports surveillance for measles, rubella and congenial rubella syndrome in 191 counties. This paper describes the overall structure and function of the GMRLN and highlights the largest of the national laboratory networks, the China Measles and Rubella Laboratory Network.
Keywords: Laboratory diagnosis; Laboratory networks; Measles; Rubella; Surveillance networks.
Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene 2017. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Similar articles
-
Global Measles and Rubella Laboratory Network Support for Elimination Goals, 2010-2015.MMWR Morb Mortal Wkly Rep. 2016 May 6;65(17):438-42. doi: 10.15585/mmwr.mm6517a3. MMWR Morb Mortal Wkly Rep. 2016. PMID: 27148917
-
The Global Measles and Rubella Laboratory Network Supports High-Quality Surveillance.Vaccines (Basel). 2024 Aug 22;12(8):946. doi: 10.3390/vaccines12080946. Vaccines (Basel). 2024. PMID: 39204069 Free PMC article.
-
Genetic Characterization of Measles and Rubella Viruses Detected Through Global Measles and Rubella Elimination Surveillance, 2016-2018.MMWR Morb Mortal Wkly Rep. 2019 Jul 5;68(26):587-591. doi: 10.15585/mmwr.mm6826a3. MMWR Morb Mortal Wkly Rep. 2019. PMID: 31269012 Free PMC article.
-
Integrating measles and rubella surveillance: the experience in the Caribbean.J Infect Dis. 2003 May 15;187 Suppl 1:S153-7. doi: 10.1086/368031. J Infect Dis. 2003. PMID: 12721907 Review.
-
Building Quality Control for Molecular Assays in the Global Measles and Rubella Laboratory Network.Vaccines (Basel). 2024 Jul 23;12(8):824. doi: 10.3390/vaccines12080824. Vaccines (Basel). 2024. PMID: 39203950 Free PMC article. Review.
Cited by
-
Understanding Mumps Dynamics: Epidemiological Traits and Breakthrough Infections in the Population under 15 Years of Age in Jiangsu Province, China, 2023.Vaccines (Basel). 2024 Aug 29;12(9):986. doi: 10.3390/vaccines12090986. Vaccines (Basel). 2024. PMID: 39340017 Free PMC article.
-
Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysis.Lancet Infect Dis. 2021 Feb;21(2):286-295. doi: 10.1016/S1473-3099(20)30442-4. Epub 2020 Sep 1. Lancet Infect Dis. 2021. PMID: 32888410 Free PMC article.
-
Epidemiological Characteristics of Notifiable Respiratory Infectious Diseases in Mainland China from 2010 to 2018.Int J Environ Res Public Health. 2023 Feb 23;20(5):3946. doi: 10.3390/ijerph20053946. Int J Environ Res Public Health. 2023. PMID: 36900957 Free PMC article.
-
Epidemic risks of measles and rubella in China: a systematic review and meta-analysis.World J Pediatr. 2024 Dec;20(12):1223-1239. doi: 10.1007/s12519-024-00859-2. Epub 2024 Dec 3. World J Pediatr. 2024. PMID: 39627646
-
Importation and circulation of rubella virus lineages 1E-L2 and 2B-L2c between 2018 and 2021 in China: Virus evolution and spatial-temporal transmission characteristics.Virus Evol. 2022 Sep 6;8(2):veac083. doi: 10.1093/ve/veac083. eCollection 2022. Virus Evol. 2022. PMID: 36533147 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical